Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform.

G2B-001, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancers.